Lytos is a biotech platform company tackling AMR with technologies that disrupt biofilms, kill pathogens, and replace traditional chemicals.
Lytos Technologies, Inc. has raised $6.3M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
Lytos Technologies, Inc.'s investors include Shenandoah Valley Founders Group, CAV Angels.
Lytos Technologies, Inc. is headquartered in Charlottesville, United States.
Lytos is a biotech platform company tackling AMR with technologies that disrupt biofilms, kill pathogens, and replace traditional chemicals.
Lytos Technologies, Inc. is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lytos Technologies, Inc. — Funding & Investors." VCBacked, January 1, 2025, https://www.vcbacked.co/company/lytos-technologies-inc. Accessed September 30, 2026.
VCBacked. (2025). Lytos Technologies, Inc. — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/lytos-technologies-inc
{{cite web |title=Lytos Technologies, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/lytos-technologies-inc |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated